(Allergan plc)

	AGN latest price $263.2581 (-3.62%) ($260.3722 - $272.6491) on Wed. Mar. 16, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.75% (three month average)
RSI	34
Latest Price	$263.2581(-3.62%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -1.2% a day on average for past five trading days.
Weekly Trend	AGN declines -1.2% a week on average for past two weeks.
Market Behavior	Broad based rally for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(51%)    XLV(50%)    XBI(45%)    ARKG(42%)    SPY(41%)
Factors Impacting AGN price	AGN will decline at least -0.875% in a week (0% probabilities).   VIXM(-29%)    TLT(-16%)    UUP(-12%)    SHY(-5%)    IPO(-3%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.875% (StdDev 1.75%)
Hourly BBV	0 ()
Intraday Trend	-3.4%

Resistance Level	$278.11
5 Day Moving Average	$277.39(-5.09%)
10 Day Moving Average	$277.65(-5.18%)
20 Day Moving Average	$278.11(-5.34%)
To recent high	-13.4%
To recent low	2.4%
Market Cap	$86.796b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed